Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 35,100 calls trading, 5x expected, and implied vol increasing almost 42 points to 161.96%. 10/24 weekly 7 calls and 10/24 weekly 7.5 calls are the most active options, with total volume in those strikes near 8,700 contracts. The Put/Call Ratio is 0.05. Earnings are expected on November 6th.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Unusually active option classes on open October 20th
- Recursion Pharmaceuticals call volume above normal and directionally bullish
- Recursion Pharmaceuticals rises 17.9%
- Unusually active option classes on open September 25th
- Strategic Growth and Unique Positioning Drive Buy Rating for Recursion Pharmaceuticals